{"denoms":[{"counts":[{"groupId":"BG000","value":"255"},{"groupId":"BG001","value":"254"},{"groupId":"BG002","value":"509"}],"units":"Participants"}],"groups":[{"description":"Participants were randomized to receive treatment according to the local SOC chemotherapy (lurbinectedin, topotecan, or amrubicin \\[Japan only\\]) in 21-day cycles.","id":"BG000","title":"Standard of Care (SOC)"},{"description":"Participants were randomized to receive tarlatamab as an IV infusion: A step dose of 1 mg on Cycle 1 Day 1 followed by the target dose 10 mg on Cycle 1 Day 8, Cycle 1 Day 15, and Q2W thereafter.","id":"BG001","title":"Tarlatamab 1 mg to 10 mg Q2W"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"9.2","value":"64.2"},{"groupId":"BG001","spread":"9.4","value":"63.6"},{"groupId":"BG002","spread":"9.3","value":"63.9"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"86"},{"groupId":"BG001","value":"72"},{"groupId":"BG002","value":"158"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"169"},{"groupId":"BG001","value":"182"},{"groupId":"BG002","value":"351"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"23"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"128"},{"groupId":"BG001","value":"140"},{"groupId":"BG002","value":"268"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"116"},{"groupId":"BG001","value":"102"},{"groupId":"BG002","value":"218"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"107"},{"groupId":"BG001","value":"97"},{"groupId":"BG002","value":"204"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"139"},{"groupId":"BG001","value":"152"},{"groupId":"BG002","value":"291"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"2"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"4"}],"title":"Other"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"}],"populationDescription":"The intent-to-treat (ITT) analysis set included all randomized participants."}